Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 5/20 | 0.55 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | CDC25B | P30305 | 1/20 | 0.52 |
| ▸ | KDR | P35968 | 3/20 | 0.52 |
| ▸ | AURKA | O14965 | 1/20 | 0.52 |
| ▸ | MET | P08581 | 1/20 | 0.52 |
| ▸ | TEK | Q02763 | 1/20 | 0.52 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.52 |
| ▸ | CNR2 | P34972 | 4/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10856546 | 0.87 | MTNR1A (0.70) | MTNR1AMTNR1BALDH1A1CYP3A4HPGD | |
| SCHEMBL2510203 | 0.87 | CDC25B (0.64) | MTNR1AMTNR1BALDH1A1HPGDCDC25B | |
| SCHEMBL31613816 | 0.87 | CDC25B (0.64) | MTNR1AMTNR1BALDH1A1HPGDCDC25B | |
| SCHEMBL31392475 | 0.87 | MTNR1A (0.70) | MTNR1AMTNR1BALDH1A1CYP3A4HPGD | |
| SCHEMBL31613069 | 0.85 | KDR (0.67) | MTNR1AMTNR1BALDH1A1CDC25BKDR | |
| SCHEMBL2237855 | 0.85 | MTNR1A (0.56) | MTNR1AMTNR1BALDH1A1HPGDCDC25B | |
| SCHEMBL2509951 | 0.85 | MTNR1A (0.52) | MTNR1AMTNR1BCDC25BKDRAURKA | |
| SCHEMBL27792854 | 0.83 | CYP1A2 (0.48) | MTNR1AMTNR1BCDC25BKDRAURKA | |
| SCHEMBL11739020 | 0.83 | MTNR1A (0.51) | MTNR1AMTNR1BCDC25BKDRAURKA | |
| SCHEMBL11470996 | 0.83 | CNR2 (0.54) | MTNR1AMTNR1BCDC25BKDRAURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017066103-A1 | NOVEL COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS | AURIMMED PHARMA, INC. (US) | 2017-04-20 | — | — | WO | disclosed |
| WO-2014083156-A2 | HYDROCARBON MARKERS | O'REILLY JOHN (IE) | 2014-06-05 | — | — | WO | disclosed |
| WO-2014083156-A2 | HYDROCARBON MARKERS | O'REILLY JOHN (IE) | 2014-06-05 | — | — | WO | disclosed |
| US-8299055-B2 | 8-substituted isoquinoline derivative and the use thereof | ASAHI KASEI PHARMA CORPORATION (JP) | 2012-10-30 | — | — | US | disclosed |
| US-20100261701-A1 | 8-Substituted isoquinoline derivative and the use thereof | ASAHI KASEI PHARMA CORPORATION (JP) | 2010-10-14 | — | — | US | disclosed |
| WO-2010038465-A1 | 8-SUBSTITUTED ISOQUINOLINE DERIVATIVE AND USE THEREOF | 旭化成ファーマ株式会社 (JP) | 2010-04-08 | — | — | WO | disclosed |
| EP-0511152-A2 | Quinoxaline compounds, their preparation and use | NOVO NORDISK A/S (DK) | 1992-10-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100261701-A1 | 8-Substituted isoquinoline derivative and the use thereof | RELA, NFKBIA, NFKB2 | MTNR1A 689/4885MTNR1B 811/4885ALDH1A1 1380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.